Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

VOCARVI - Health Canada Drug Approval Details

Approvals/Health Canada/VOCARVI

Authorized

STANDARD

VOCARVI

Sterimax Inc🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: 233923faa1117848
Company: Sterimax Inc
Type: Standard

Approval Details

Approval Id: 233923faa1117848
Drug Approval Canada Name: VOCARVI
Product Name: VOCARVI
Status: Marketed
Status Date: 2021-03-30
Original Market Date: 2021-03-30
Din: 02505924
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Prescription
Ahfs: 08:18.92
Atc Original: J05AD01 FOSCARNET
Atc Name: j 05 ad 01
Aig Number: 0123310001
Company Name: Sterimax Inc
Company Address: 2770 Portland Drive, Oakville, Ontario, Canada, L6H 6R4

Active Ingredients

FOSCARNET SODIUM

24 MG / ML

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

233923faa1117848

Type

Standard

Back to Health Canada Approvals